cell
Showing 9976 - 10000 of >10,000
Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Cancer, Melanoma Trial in Worldwide (MGC018, retifanlimab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +5 more
- MGC018
- retifanlimab
-
Santa Monica, California
- +19 more
Feb 14, 2022
Glioblastoma, Malignant Solid Tumor Trial in Philadelphia (Biospecimen Collection)
Recruiting
- Glioblastoma
- Malignant Solid Neoplasm
- Biospecimen Collection
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Mar 26, 2021
Interstitial Cystitis, Stem Cell Transplant, Mesenchymal Stem Cell Trial in Seoul (MR-MC-01)
Unknown status
- Interstitial Cystitis
- +2 more
-
Seoul, Korea, Republic ofDepartment of Urology, Asan Medical Center
Oct 26, 2020
Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,
Active, not recruiting
- Non Small Cell Lung Cancer
- +3 more
- GRT-C901
- +3 more
-
Phoenix, Arizona
- +10 more
Aug 31, 2021
CD19+ Relapse/Refractory B-ALL Trial in Beijing (CAR-T-19 Cells)
Recruiting
- CD19+ Relapse/Refractory B-ALL
- CAR-T-19 Cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Feb 26, 2022
Myeloma, Lymphoma, Autologous Transplant Trial in Angers, Le Mans (Adapted Physical Activity)
Recruiting
- Myeloma
- +2 more
- Adapted Physical Activity
-
Angers, France
- +1 more
Oct 7, 2021
Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)
Recruiting
- Glioma
- +6 more
- Metronomic Cyclophosphamide
- Thalidomide
-
Saint Louis, MissouriWashington University School of Medicine
Sep 22, 2021
Metastatic Renal Cell Carcinoma Treated With Cabozantinib Trial in Durham, Raleigh (Usability of an electronic symptom
Terminated
- Metastatic Renal Cell Carcinoma Treated With Cabozantinib
- Usability of an electronic symptom management application
-
Durham, North Carolina
- +1 more
Jun 10, 2021
Solid Tumor, Cancer Trial in Geneva (Treatment)
Active, not recruiting
- Solid Tumor
- Cancer
- Treatment
-
Geneva, Genève, SwitzerlandHopitaux Universitaires de Genève - HUG
Jan 26, 2022
Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)
Recruiting
- Advanced Solid Tumor
- +6 more
- vobramitamab duocarmazine
- lorigerlimab
-
Los Angeles, California
- +7 more
Jan 10, 2023
Glucose Homeostasis in Pseudohypoparathyroidism
Terminated
- Pseudohypoparathyroidism and Pseudopseudohypoparathyroidism
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
May 26, 2021
Indian Children With Acute Lymphoblastic Leukemia
Not yet recruiting
- ALL, Childhood
- +7 more
-
New Delhi, India
- +1 more
Aug 22, 2022
Multiple Myeloma Trial in Huixquilucan (Daratumumab Only Product in Parenteral Dose Form)
Withdrawn
- Multiple Myeloma
- Daratumumab Only Product in Parenteral Dose Form
-
Huixquilucan, Estado De México, MexicoGrupo Cooperativo de Hemopatías Malignas
Jul 5, 2021
Lung Cancer, Non-Small Cell Trial in Worldwide (Dostarlimab, Pembrolizumab, Chemotherapy)
Active, not recruiting
- Lung Cancer, Non-Small Cell
- Dostarlimab
- +2 more
-
Lone Tree, Colorado
- +65 more
Jun 26, 2022
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +18 more
- everolimus
- +6 more
-
Scottsdale, Arizona
- +1 more
Sep 28, 2020
Leukemia Trial in Bronx (deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins)
Completed
- Leukemia
- deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins
-
Bronx, New YorkAlbert Einstein Cancer Center at Albert Einstein College of Medi
Apr 9, 2021
Medication Adherence Trial in Los Angeles (Cell Phone Support)
Recruiting
- Medication Adherence
- Cell Phone Support
-
Los Angeles, CaliforniaChildren's Hospital Los Angeles
Mar 15, 2021
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Cyclophosphamide
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 20, 2023
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)
Active, not recruiting
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
- autologous CAR.CD30 EBV specific-CTLs
-
Houston, Texas
- +1 more
Feb 4, 2022
CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
Recruiting
- Stomach Neoplasms
- Metastasis
- CTC test
- ctDNA test
-
Jinzhou, Liaoning, China
- +1 more
Jan 13, 2022
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)
Terminated
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
- Venetoclax
- +3 more
-
Chicago, Illinois
- +2 more
Aug 19, 2022
Sickle Cell Disease Trial in Salvador, Ribeirao Preto (etonogestrel-releasing implant contraceptive)
Completed
- Sickle Cell Disease
- etonogestrel-releasing implant contraceptive
-
Salvador, Bahia, Brazil
- +1 more
Nov 4, 2020
Lung Cancer Trial in Rozzano (Sentinel lymph node scintigraphy)
Recruiting
- Lung Cancer
- Sentinel lymph node scintigraphy
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
Nov 24, 2021